Western Sierra Resource Corporation (WSRC) Fair Value & Analysis
Healthcare · US · Market cap $33.7K
Fair value as of: Jun 26, 2026
From 14 valuation models · updated 7 days ago
Price vs Fair Value (12 months)
12‑month range $0.0001 – $0.0002 · the $0.0001 price screens below the $0.0001 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Western Sierra Resource Corporation (WSRC) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 33/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Western Sierra Resource Corporation generated revenue of $1.2M at a net margin of 86.5%. It earns a return on equity of -1.1%. Net debt stands at $10.3M. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Western Sierra Resource Corporation operates as a gold and silver mining company with projects in Arizona, Nevada, California, and Mexico. The company primarily owns six precious metal reserves in Arizona and one in Nevada. It also manages the company's mineral resource projects covering precious metals, helium, and natural gas properties located in the Southwestern United States; and water and infrastructure assets in Northwest CO for implementation of industrial hemp irrigation, processing, and manufacture of hemp-based building materials for construction of on-site affordable housing in resort area. The company was formerly known as Western Sierra Mining Corp. and changed its name to Western Sierra Resource Corporation in September 2018. Western Sierra Resource Corporation was founded in 1907 and is based in Edmond, Oklahoma.
Revenue & earnings trend
FY2011 – FY2022 · reported fiscal years
Western Sierra Resource Corporation reported revenue of $381K in FY2022 versus $8.9K in FY2011, a compound +40.6%/yr. Reported net income was $250K in FY2022.
Is WSRC fairly valued? → Check now
Similar stocks
6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 1276 | HK$57.85 | HK$29.84 | -48% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,782 | ₹915.92 | -49% |
| Zoetis Inc Z1TS34 | R$24.45 | R$6.33 | -74% |
| Hansoh Pharmaceutical Group 3692 | HK$29.32 | HK$23.94 | -18% |
| Divi's Laboratories Limited DIVISLAB | ₹6,623 | ₹1,461 | -78% |
| Swedish Orphan Biovitrum AB SOBI | kr 444.80 | kr 440.64 | -1% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Western Sierra Resource Corporation (WSRC) undervalued?
What is the fair value of WSRC?
What is the quality score of WSRC?
What is the revenue of Western Sierra Resource Corporation (WSRC)?
What is the net profit margin of WSRC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.